Drawing for CELL REVEAL

USPTO serial 87274473

CELL REVEAL

Reviewed by CopyMark Law Group

Reg. 5481952Status 702Registered
Filing date
Status date
Registration date
May 29, 2018
Examiner
BUTLER, ANDREA P
Law office
TMO LAW OFFICE 124

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with CELL REVEAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Hui Zhang

Hui Zhang RABIN & BERDO, P.C.2650 Park Tower Drive, Suite 800Vienna, VA 22180UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009AUTOMATIC FLUID-COMPOSITION CONTROL MACHINES AND INSTRUMENTS; CHIPSETS; CIRCUIT BOARDS PROVIDED WITH INTEGRATED CIRCUITS; COMPUTER APPLICATION SOFTWARE FOR COMPUTER, LAPTOP AND HANDHELD COMPUTERS, NAMELY, SOFTWARE FOR PATHOLOGICAL IMAGE ANALYSIS AND MACHINE CONTROL; COMPUTER HARDWARE AND SOFTWARE, FOR USE WITH MEDICAL PATIENT MONITORING EQUIPMENT, FOR RECEIVING, PROCESSING, TRANSMITTING AND DISPLAYING DATA; COMPUTER-CONTROLLED ELECTRONIC APPARATUS FOR ELECTROPHYSIOLOGICAL MEASUREMENT AND TESTING OF CELLS; INTEGRATED CIRCUITS; LABORATORY APPARATUS AND INSTRUMENTS FOR EXTRACTING DNA, NOT FOR MEDICAL PURPOSES; MEDICAL LABORATORY RESEARCH INSTRUMENTS FOR CELL CAPTURE AND ISOLATION SYSTEM; RESEARCH LABORATORY ANALYZERS FOR MEASURING, TESTING AND ANALYZING BLOOD AND OTHER BODILY FLUIDSACTIVENov 28, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 20, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 6, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Feb 6, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Feb 6, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 16, 2023E815TEAS SECTION 8 & 15 RECEIVED—
May 29, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 29, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 25, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 24, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 4, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 4, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 17, 2018IUAFUSE AMENDMENT FILED—
Mar 17, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 3, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 8, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 8, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 19, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 30, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 12, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 12, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 12, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 24, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2017DOCKASSIGNED TO EXAMINER—
Dec 28, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 23, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance